DC's latest movie is putting a disturbing new face on the comic-book universe-and critics are arguing over what lies beneath it. Ahead of its October 23 U.S. theatrical release, Clayface is drawing praise for Tom Rhys Harries' performance and its gruesome transformation scenes, alongside complaints that its storytelling struggles to match its visual ambition.
Directed by James Watkins from a screenplay by Mike Flanagan and Hossein Amini, the film follows Matt Hagen, a rising actor whose career unravels after a violent attack leaves him disfigured. An experimental treatment offers a chance to recover his appearance, but its horrifying consequences send him toward a new identity as one of Batman's most unsettling adversaries. Naomi Ackie plays the scientist whose intervention becomes entangled with his transformation.
The premise turns Hollywood's obsession with appearance into a physical nightmare. For The Playlist's Rodrigo Perez, the film's exploration of vanity, identity, and impostor syndrome offers intriguing material, but its impressive visuals cannot overcome an emotionally misjudged tragedy. His response captures one of the central disagreements surrounding the release: whether the suffering beneath the spectacle feels convincing.
Other reviewers have embraced its unpleasant pleasures. TheWrap's William Bibbiani calls the monster movie "mostly effective," positioning Watkins' approach within a tradition of classic horror. That response suggests the film's strongest appeal may lie in how fully it commits to making its central transformation uncomfortable.
The Houston Chronicle is more enthusiastic, praising a dark and compelling origin story that gives a lesser-known DC villain emotional weight. Its review welcomes the film's focus on a broken actor and his desperate reinvention, finding a creative success in the combination of personal tragedy and horror.
Yet even Harries' performance has not persuaded every critic. ComicBookMovie's Josh Wilding praises the leading man while dismissing the overall film as disappointingly tame and forgettable. Meanwhile, /Film argues that the bloody spectacle feels underdeveloped, with the suggestion of a stronger movie lingering around its edges.
For audiences deciding whether to buy a ticket, the reviews point toward a specific proposition: an R-rated villain story built around bodily transformation, wounded ambition, and revenge. The critical divide concerns whether those ingredients become a satisfying tragedy or remain a collection of striking horror moments. That question now passes to moviegoers as Clayface opens in U.S. theaters on October 23.
